publicações selecionadas
-
artigo académico
- Recent Advances in the Selection of Cancer-Specific Aptamers for the Development of Biosensors. Current Medicinal Chemistry. 2022
-
artigo de conferência
-
artigo de revista
- In Vitro CRISPR/Cas9 Transfection and Gene-Editing Mediated by Multivalent Cationic Liposome-DNA Complexes. Pharmaceutics. 2022
- In Vitro CRISPR/Cas9 Transfection and Gene-Editing Mediated by Multivalent Cationic Liposome-DNA Complexes. Pharmaceutics. 2022
- In vitro selection of DNA aptamers against human osteosarcoma. Investigational New Drugs. 2022
- In vitro selection of DNA aptamers against human osteosarcoma. Investigational New Drugs. 2022
- Identification of novel aptamers targeting Cathepsin B-overexpressing prostate cancer cells. Molecular Systems Design & Engineering. 2022
- Selection of aptamers against triple negative breast cancer cells using high throughput sequencing. Acta Cytologica. 2021
-
capítulo de livro
-
documento
- Non-viral delivery of CRISPR/Cas9 DNA for gene editing via multivalent cationic liposome system 2022
- Targeting oncogenic microRNAs in triple negative breast cancer using a CRISPR/Cas9-based approach 2020
- Selection of a molecule that specifically targets the cell-surface Human Epidermal growth factor Receptor 2: in silico docking simulation 2017
- In silico selection of an ssDNA aptamer against HER2-positive breast cancer cells using computational docking simulation 2017
-
poster de conferência
-
teses